Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1175840

Beneficial effect of ACE inhibitors on kidney function in polycythemia vera


Krečak, Ivan; Morić Perić, Martina; Zekanović, Ivan; Holik, Hrvoje; Coha, Božena; Gverić-Krečak, Velka; Lucijanić, Marko
Beneficial effect of ACE inhibitors on kidney function in polycythemia vera // Wiener klinische Wochenschrift, 133 (2021), 15-16; 808-815 doi:10.1007/s00508-021-01812-3 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1175840 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Beneficial effect of ACE inhibitors on kidney function in polycythemia vera

Autori
Krečak, Ivan ; Morić Perić, Martina ; Zekanović, Ivan ; Holik, Hrvoje ; Coha, Božena ; Gverić-Krečak, Velka ; Lucijanić, Marko

Izvornik
Wiener klinische Wochenschrift (0043-5325) 133 (2021), 15-16; 808-815

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
angiotensin-converting enzyme inhibitors ; arterial hypertension ; hyperlipidemia ; renoprotection ; statins

Sažetak
Background: Reduced kidney function has been associated with worse clinical outcomes in patients with myeloproliferative neoplasms (MPN). Statins and angiotensin-converting enzyme inhibitors (ACE-i) have renoprotective properties and their pleiotropic effects might also affect the malignant MPN clone ; however, whether concomitant use of statins and ACE‑i has a positive effect on estimated glomerular filtration rate (eGFR) in polycythemia vera (PV) patients is currently unknown. Methods: This multicenter retrospective study investigated effects of statins and ACE‑i on 12-month eGFR dynamics in 75 PV patients. Results: Of the patients 25 (33.3%) had a 10% or more increase in eGFR at 12 months. Univariately, statins (55.5% vs. 16.3% ; p = 0.022), ACE‑i (61% vs. 24.6% ; p = 0.004), male sex (54.3%, vs. 15% ; p < 0.001) and the absence of chronic kidney disease (CKD, 45.5% vs. 16.1% ; p = 0.008) were statistically significantly associated with an improvement in eGFR. ACE‑i (p = 0.008), CKD (p < 0.001), male sex (p = 0.004) and higher baseline eGFR (p = 0.007) remained statistically significantly associated with an improvement in eGFR in the multivariate logistic regression model also including statins, hydroxyurea, high-risk disease, cardiovascular risk factors, chronic heart failure and baseline hematocrit. Conclusion: The ACE‑i might have renoprotective properties in PV. Further studies are needed to elucidate whether the use of these drugs could also affect other MPN-related outcomes.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Zagreb,
Opća bolnica Šibenik,
Opća bolnica "Dr. Josip Benčević",
Klinička bolnica "Dubrava",
Opća bolnica Zadar

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Krečak, Ivan; Morić Perić, Martina; Zekanović, Ivan; Holik, Hrvoje; Coha, Božena; Gverić-Krečak, Velka; Lucijanić, Marko
Beneficial effect of ACE inhibitors on kidney function in polycythemia vera // Wiener klinische Wochenschrift, 133 (2021), 15-16; 808-815 doi:10.1007/s00508-021-01812-3 (međunarodna recenzija, članak, znanstveni)
Krečak, I., Morić Perić, M., Zekanović, I., Holik, H., Coha, B., Gverić-Krečak, V. & Lucijanić, M. (2021) Beneficial effect of ACE inhibitors on kidney function in polycythemia vera. Wiener klinische Wochenschrift, 133 (15-16), 808-815 doi:10.1007/s00508-021-01812-3.
@article{article, author = {Kre\v{c}ak, Ivan and Mori\'{c} Peri\'{c}, Martina and Zekanovi\'{c}, Ivan and Holik, Hrvoje and Coha, Bo\v{z}ena and Gveri\'{c}-Kre\v{c}ak, Velka and Lucijani\'{c}, Marko}, year = {2021}, pages = {808-815}, DOI = {10.1007/s00508-021-01812-3}, keywords = {angiotensin-converting enzyme inhibitors, arterial hypertension, hyperlipidemia, renoprotection, statins}, journal = {Wiener klinische Wochenschrift}, doi = {10.1007/s00508-021-01812-3}, volume = {133}, number = {15-16}, issn = {0043-5325}, title = {Beneficial effect of ACE inhibitors on kidney function in polycythemia vera}, keyword = {angiotensin-converting enzyme inhibitors, arterial hypertension, hyperlipidemia, renoprotection, statins} }
@article{article, author = {Kre\v{c}ak, Ivan and Mori\'{c} Peri\'{c}, Martina and Zekanovi\'{c}, Ivan and Holik, Hrvoje and Coha, Bo\v{z}ena and Gveri\'{c}-Kre\v{c}ak, Velka and Lucijani\'{c}, Marko}, year = {2021}, pages = {808-815}, DOI = {10.1007/s00508-021-01812-3}, keywords = {angiotensin-converting enzyme inhibitors, arterial hypertension, hyperlipidemia, renoprotection, statins}, journal = {Wiener klinische Wochenschrift}, doi = {10.1007/s00508-021-01812-3}, volume = {133}, number = {15-16}, issn = {0043-5325}, title = {Beneficial effect of ACE inhibitors on kidney function in polycythemia vera}, keyword = {angiotensin-converting enzyme inhibitors, arterial hypertension, hyperlipidemia, renoprotection, statins} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font